Mercado de software de farmacovigilancia y seguridad de medicamentos: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHC00002557
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 186
Buy Now

[Informe de investigación] Se espera que el mercado de software de farmacovigilancia y seguridad de los medicamentos alcance los 292,97 millones de dólares en 2027 desde los 160,67 millones de dólares de 2019. Se estima que el mercado crecerá con una tasa compuesta anual del 7,6% entre 2020 y 2027. .

El alcance del mercado de software de farmacovigilancia y seguridad de medicamentos incluye el tipo de software, el tipo de producto, el usuario final y la región. El mercado de software de farmacovigilancia y seguridad de medicamentos, según la región, está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de software de farmacovigilancia y seguridad de los medicamentos haciendo hincapié en varios parámetros, como tendencias del mercado, avances tecnológicos, dinámica del mercado y análisis del panorama competitivo de los principales actores del mercado en todo el mundo. mundo. También incluye análisis de impacto de COVID-19 en todas las regiones.

Regiones lucrativas para el mercado de software de farmacovigilancia y seguridad de los medicamentos


Perspectivas del mercado

< p>Globalización de la farmacovigilancia

La farmacovigilancia son los procesos para monitorear y evaluar las reacciones adversas a los medicamentos y es un componente clave de los sistemas eficaces de regulación de medicamentos, la práctica clínica y los programas de salud pública. El número de reacciones adversas a medicamentos (RAM) notificadas resultó en un aumento en el volumen de datos manejados. En la actual red global de centros de farmacovigilancia coordinados por el Centro de Vigilancia de Uppsala. La farmacovigilancia es una parte fundamental e integral de la investigación clínica y actualmente está creciendo en muchos países. Hoy en día, muchos centros de farmacovigilancia trabajan para monitorear la seguridad de los medicamentos en este ámbito global; sin embargo, en el cambio de milenio, la farmacovigilancia enfrenta grandes desafíos en el aspecto de una mejor seguridad y monitoreo de los medicamentos.

La notificación y el almacenamiento centralizados de Los informes de reacciones adversas al medicamento ayudarán a monitorear y prevenir futuras reacciones adversas al medicamento. La Agencia Europea de Medicamentos (EMA) y la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) se fortalecen en el área de farmacovigilancia al interactuar en diferentes temas relacionados con la seguridad poscomercialización y el intercambio científico. Debates sobre prioridades como biosimilares, medicamentos para tratar el cáncer, medicamentos huérfanos, medicamentos para niños y hemoderivados, entre otros temas.

Así, el aumento de la globalización en el sector de la farmacovigilancia ayuda en el software de seguridad de los medicamentos. Mejora la calidad y eficacia del software de farmacovigilancia y seguridad de los medicamentos y se espera que favorezca el crecimiento del mercado durante el período de pronóstico.

Información basada en el tipo de software

Basado en el tipo de software el mercado está segmentado en software de notificación de eventos adversos, software de auditorías de seguridad de medicamentos, software de seguimiento de problemas y software totalmente integrado. En 2019, el segmento de software de notificación de eventos adversos tuvo la mayor participación del mercado, por software. Sin embargo, se prevé que el segmento de software totalmente integrado crezca al ritmo más alto durante el período de pronóstico debido a su precisión para evitar la redundancia de datos mediante la eliminación de errores y el seguimiento de informes de seguridad de casos individuales.

Mercado global de software de farmacovigilancia y seguridad de los medicamentos, por tipo de software: 2019 y 2027


Información basada en el modo de entrega

Según el modo de entrega, el mercado se segmenta en local y basado en la nube. En 2019, el segmento local tuvo la mayor participación del mercado, por modo de entrega. Sin embargo, se espera que el segmento basado en la nube crezca al ritmo más rápido durante los próximos años debido a los beneficios asociados, como el acceso remoto a los datos y el seguimiento de datos en tiempo real.

Información basada en el usuario final

Según el usuario final, el mercado se segmenta en empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato (CRO) y empresas de subcontratación de procesos comerciales (BPO). En 2019, el segmento de organizaciones de investigación por contrato tuvo la mayor participación de mercado, por usuario final. Además, se espera que el segmento de organizaciones de investigación por contrato crezca al ritmo más rápido durante los próximos años debido al aumento de las actividades de descubrimiento de fármacos en las empresas farmacéuticas.

Perspectivas estratégicas

Las empresas suelen adoptar estrategias inorgánicas como asociaciones, fusiones y adquisiciones para satisfacer la demanda cambiante de los clientes y mantener su marca en todo el mundo. Los actores del mercado que operan en el mercado de software de farmacovigilancia y seguridad de los medicamentos también adoptan estrategias orgánicas, como el lanzamiento y la expansión de productos, para ampliar su presencia y cartera de productos en todo el mundo, así como para satisfacer la creciente demanda.

 

Por tipo de software

  • Software totalmente integrado
  • Software de informes de eventos adversos
  • Software de auditorías de seguridad de medicamentos
  • Software de seguimiento de problemas

Por modo de entrega

  • Basado en la nube< /li>
  • En las instalaciones

Por usuario final

  • Organizaciones de investigación por contrato
  • Empresas farmacéuticas y biotecnológicas
  • Subcontratación de procesos de negocio

Por geografía

  • América del Norte
    • Estados Unidos< /li>
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de APAC
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de MEA
  • América del Sur y Central (SCAM)
    • Brasil
    • Argentina
    • Resto de SCAM
  • Perfiles de la empresa

    • Veeva Systems ;                           ;         
    • IQVIA Inc.                         &n bsp;             
    • Ennov ;                           ;                
    • Cubo AB                         &n bsp;             
    • United Biosource LLC ;              
    • ArisGlobal LLC                            
    • Sparta Systems                          
    • Oracle Corporation                    
    • Sarjen Systems Pvt. Limitado. Ltd nbsp;        
    • EXTEDO ;                           ;             
    • Aplicación Max ;                        
    • Aplicaciones comerciales en línea, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Pharmacovigilance and Drug Safety Software ?

Pharmacovigilance (PV) plays an important role in drug monitoring and identification of drug interactions with human. The fully integrated software segment are expected to contribute in the growth of pharmacovigilance and drug safety market.

What are the driving factors for the Pharmacovigilance and Drug Safety Software market across the globe?

Rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology are likely to have a negative impact on the growth of the market in the coming years.

What is the cost of Pharmacovigilance and Drug Safety Software?

The costs of the pharmacovigilance and drug safety software are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product and software types.

The List of Companies - Pharmacovigilance and Drug Safety Software Market

  1. Veeva Systems          
  2. IQVIA Inc.      
  3. Ennov            
  4. AB Cube        
  5. United Biosource LLC             
  6. ArisGlobal LLC           
  7. Sparta Systems         
  8. Oracle Corporation     
  9. Sarjen Systems Pvt. Ltd         
  10. EXTEDO        
  11. Maxapplication           
  12. Online Business Applications, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports